2023-02-14 Senate Journal

hist162040 Report received from Agency, January 30, 2023.

hist162368 Referred to the committee on Health, February 14, 2023.

_____________

The committee on Health reported and recommended:

Senate Clearinghouse Rule 20-053

Relating to continuing medical education for physicians.

hist162492 No action taken on February 14, 2023.

hist162493 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 21-016

Relating to telehealth.

hist162490 No action taken on February 14, 2023.

hist162491 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 21-033

Relating to telehealth.

hist162488 No action taken on February 14, 2023.

hist162489 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 21-074

Relating to name and address change, floor design, procedures for disciplinary proceedings, superseded references, and technical correction.

hist162486 No action taken on February 14, 2023.

hist162487 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 21-086

Relating to requirements for class III permits for anesthesia.

hist162484 No action taken on February 14, 2023.

hist162485 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-011

Relating to scheduling Crotonyl Fentanyl.

hist162482 No action taken on February 14, 2023.

hist162483 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-014

Relating to scheduling Remimazolam.

hist162480 No action taken on February 14, 2023.

hist162481 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-015

Relating to radiation protection requirements for radiation-producing machines and radioactive materials.

hist162478 No action taken on February 14, 2023.

hist162479 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-016

Relating to scheduling Brorphine.

hist162476 No action taken on February 14, 2023.

hist162477 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-019

Relating to service fund for people who are deaf, deafblind or hard of hearing.

hist162474 No action taken on February 14, 2023.

hist162475 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-026

Relating to long-term care services and Medical Assistance fair hearing process.

hist162472 No action taken on February 14, 2023.

hist162473 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-032

Relating to scheduling Serdexmethylphenidate.

hist162470 No action taken on February 14, 2023.

hist162471 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-033

Relating to scheduling ten (10) fentanyl related substances.

hist162445 No action taken on February 14, 2023.

hist162446 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-034

Relating to scheduling Alfaxalone.

hist162443 No action taken on February 14, 2023.

hist162444 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-035

Relating to Excluding 6-beta-Naltrexol.

hist162441 No action taken on February 14, 2023.

hist162442 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-036

Relating to scheduling Fospropofol.

hist162439 No action taken on February 14, 2023.

hist162440 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-037

Relating to scheduling Embutramide.

hist162437 No action taken on February 14, 2023.

hist162438 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-038

Relating to scheduling Perampanel.

hist162435 No action taken on February 14, 2023.

hist162436 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-039

Relating to scheduling Lacosamide.

hist162433 No action taken on February 14, 2023.

hist162434 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-040

Relating to transferring 1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile, immediate precursors to phencyclidine, also known as PCP.

hist162431 No action taken on February 14, 2023.

hist162432 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-043

Relating to telehealth.

hist162429 No action taken on February 14, 2023.

hist162430 Referred to the joint committee for review of Administrative Rules, February 14, 2023.

Senate Clearinghouse Rule 22-046